Matches in Wikidata for { <http://www.wikidata.org/entity/Q98497985> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q98497985 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q98497985 description "scientific article published on 24 July 2020" @default.
- Q98497985 description "wetenschappelijk artikel" @default.
- Q98497985 description "наукова стаття, опублікована 24 липня 2020" @default.
- Q98497985 name "Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer" @default.
- Q98497985 name "Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer" @default.
- Q98497985 type Item @default.
- Q98497985 label "Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer" @default.
- Q98497985 label "Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer" @default.
- Q98497985 prefLabel "Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer" @default.
- Q98497985 prefLabel "Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer" @default.
- Q98497985 P1433 Q98497985-2DF4E499-730C-466F-9E13-97A19D6847A1 @default.
- Q98497985 P1476 Q98497985-16EA67D1-11F2-4C3E-81D3-49740EA3A592 @default.
- Q98497985 P2093 Q98497985-20C99980-665D-4E67-B0F1-B1D33B717668 @default.
- Q98497985 P2093 Q98497985-3A2F6557-ED38-479D-BE92-2C350243A4C9 @default.
- Q98497985 P2093 Q98497985-4538CFCA-2FF5-45BD-B74D-1042A65B7E37 @default.
- Q98497985 P2093 Q98497985-7C8C1FF5-F6A9-4EFA-BB3C-D7D760E560A7 @default.
- Q98497985 P2093 Q98497985-95DD4DBC-07AD-46F6-9457-156D4C752072 @default.
- Q98497985 P2093 Q98497985-B02E9EED-2756-4F30-8E4E-17D17B080F1D @default.
- Q98497985 P2093 Q98497985-BC1703D6-4605-4661-A8BC-5E35F604241F @default.
- Q98497985 P31 Q98497985-CD19647C-F8C4-4B49-8851-F0A8DB5DFF9B @default.
- Q98497985 P356 Q98497985-90232187-3D4A-499A-AEC0-89F9983C76E3 @default.
- Q98497985 P577 Q98497985-BBCBC33B-CB29-4D02-9663-735120ADBD52 @default.
- Q98497985 P698 Q98497985-E35E38B8-C92E-4768-97C4-3CDC2F13830A @default.
- Q98497985 P921 Q98497985-200527AF-7BE8-453F-A7B1-CCC30A0863C2 @default.
- Q98497985 P356 J.CLBC.2020.07.012 @default.
- Q98497985 P698 32800494 @default.
- Q98497985 P1433 Q332245 @default.
- Q98497985 P1476 "Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer" @default.
- Q98497985 P2093 "Akira Tangoku" @default.
- Q98497985 P2093 "Hiroaki Toba" @default.
- Q98497985 P2093 "Hirokazu Takechi" @default.
- Q98497985 P2093 "Mariko Aoyama" @default.
- Q98497985 P2093 "Masami Morimoto" @default.
- Q98497985 P2093 "Misako Nakagawa" @default.
- Q98497985 P2093 "Takahiro Yoshida" @default.
- Q98497985 P31 Q13442814 @default.
- Q98497985 P356 "10.1016/J.CLBC.2020.07.012" @default.
- Q98497985 P577 "2020-07-24T00:00:00Z" @default.
- Q98497985 P698 "32800494" @default.
- Q98497985 P921 Q12859063 @default.